Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Via Nova Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Via Nova Therapeutics

Via Nova Therapeutics

Series A

Via Nova Therapeutics develops innovative treatments for acute and subacute viral infections.

HQ
Oakland, CA, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Via Nova Therapeutics, founded by a team of experts previously at Novartis, is dedicated to discovering and developing innovative treatments for acute and subacute viral infections where current therapies are insufficient. The company's mission is to advance the next generation of antiviral therapies and efficiently bring them to clinical settings. Their research focuses on several significant respiratory viruses, aiming to address unmet medical needs in this area.

Notable figures affiliated with Via Nova Therapeutics include its founders, who have a strong background in antiviral research from their tenure at Novartis. The company has made significant strides in its pipeline, leveraging its robust scientific foundation to develop promising antiviral candidates. Via Nova Therapeutics' impact lies in its potential to transform the treatment landscape for viral infections, offering new hope for patients with limited options.

Via Nova Therapeutics - Similar Companies

Kovina Therapeutics logo

Kovina Therapeutics

kovina.com

Antios Therapeutics logo

Antios Therapeutics

CoviCept Therapeutics logo

CoviCept Therapeutics

Vir Biotechnology logo

Vir Biotechnology

vir.bio

Vian Therapeutics logo

Vian Therapeutics

viantx.com

Vast Therapeutics logo

Vast Therapeutics

Viracta Therapeutics logo

Viracta Therapeutics

viracta.com

Virion Therapeutics logo

Virion Therapeutics

viriontx.com

Exavir Therapeutics logo

Exavir Therapeutics

Nextbiotics logo

Nextbiotics

next-biotics.com

Selva Therapeutics logo

Selva Therapeutics

Antiva Biosciences logo

Antiva Biosciences

antivabio.com

Red Queen Therapeutics logo

Red Queen Therapeutics

redqueentx.com

VintaBio logo

VintaBio

vintabio.com

AVnovum Therapeutics logo

AVnovum Therapeutics

Via Nova Therapeutics - Quick Facts

Who are Via Nova Therapeutics' competitors?

Companies similar to Via Nova Therapeutics include Kovina Therapeutics, Antios Therapeutics, CoviCept Therapeutics and Vir Biotechnology.

When was Via Nova Therapeutics founded?

Via Nova Therapeutics was founded in 2020.

Where is Via Nova Therapeutics' headquarters located?

Via Nova Therapeutics' headquarters is located in Oakland, CA, US.

When was Via Nova Therapeutics' last funding round?

Via Nova Therapeutics' most recent funding round was for $5M (USD) in September 2021.

How much has Via Nova Therapeutics raised to-date?

As of Sep 15, 2021, Via Nova Therapeutics has raised a total of $25M (USD).

How many employees does Via Nova Therapeutics have?

Via Nova Therapeutics has 5 employees as of Feb 5, 2024.

Via Nova Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Viral Therapies
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified